̽��ֱ��

A pivotal clinical trial of a 'pill-on-a-thread' test, which will decide if it becomes a new screening programme for oesophageal cancer, has welcomed its first participants.

A new test to help diagnose a condition that can lead to oesophageal cancer – developed by Cambridge researchers and trialled by the NHS – has reduced the need for invasive endoscopy in thousands of low-risk patients.

Abnormal cells that develop into oesophageal cancer – cancer that affects the tube connecting the mouth and stomach – start life as cells of the stomach, according to scientists at the ̽��ֱ�� of Cambridge.

Artificial intelligence ‘deep learning’ techniques can be used to triage suspected cases of Barrett oesophagus, a precursor to oesophageal cancer, potentially leading to faster and earlier diagnoses, say researchers at the ̽��ֱ�� of Cambridge.

DNA from tissue biopsies taken from patients with Barrett’s oesophagus – a risk factor for oesophageal cancer – could show which patients are most likely to develop the disease eight years before diagnosis, suggests a study led by researchers at the ̽��ֱ�� of Cambridge and EMBL’s European Bioinformatics Institute (EMBL-EBI).

A ‘pill on a string’ test can identify ten times more people with Barrett’s oesophagus than the usual GP route, after from a 3-year trial were published in the medical journal  ̽��ֱ��Lancet.

Kate Gross was just 36 years old when she died of cancer. Researchers at Cambridge – including her husband – are trying to ensure that others receive their diagnoses early enough to stop their cancer. 

Tailored, targeted treatment for patients with oesophageal cancer could be developed after scientists discovered that the disease can be classified into three different subtypes

A ‘pill on a string’ developed by researchers at the ̽��ֱ�� of Cambridge could help doctors detect oesophageal cancer – cancer of the gullet – at an early stage, helping them overcome the problem of wide variation between biopsies, suggests research published today in the journal Nature Genetics.

A newly-discovered gene linked to oesophageal cancer holds the promise of new treatments for this notoriously difficult-to-fight disease.